Ligand Pharma (LGND) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Ligand Pharma (LGND) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Ligand Pharma

· LGND

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

6.187 B

+0.65%

General

Market Cap: $6.19B
Enterprise Value: $6.38B
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 98.58%
Operating Margin: 34.74%
Net Profit Margin: 67.88%
FCF Margin: 45.21%
ROA: 9.02%
ROE: 20.06%
ROIC: 3.91%
Current Ratio: 31.18
Debt-to-Equity: 1.17
Revenue Per Employee: —

Valuation (TTM)

P/E: 31.78
PEG: —
P/S: 21.55
P/FCF: 47.66
P/B: 6.47
EV/EBITDA: 23.32

Growth

Rev 1Y: 60.40%

Income Statement (TTM)

Revenue: $290.54M
Gross Margin: 98.58%
Operating Expenses: $185.49M
Operating Income: $100.93M
Net Profit: $197.22M

Balance Sheet

Rev 1Y Fwd Est

8.30%

Rev 3Y (CAGR)

10.96%

Rev 5Y (CAGR)

10.39%

Rev 10Y (CAGR)

14.06%

EPS 1Y

—

EPS 1Y Fwd Est

51.81%

EPS 3Y (CAGR)

—

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

-6.59%

Cash and Equivalents: $1.01B
Working Capital: $1.41B
Total Assets: $2.19B
Net Debt: $124.75M
Total Liabilities: $1.22B
Total Equity: $967.52M

Cash Flow Statement (TTM)

Cash Flow from Operations: $131.64M
Cash Flow from Investing: -$144.78M
Cash Flow from Financing: $950.28M
Free Cash Flow: $131.37M
Capital Expenditures: $278K